Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis

Table 3 Multivariate logistic regression analysis

Variables	Odds ratio	95% CI	p value
Age (per decade)	1.57	1.04–2.48	0.03
Duration of GC use (months)	1.00	0.997–1.005	0.73
Current dose of GC (mg^a/day)	0.96	0.90–1.01	0.12
BMD T-score^b	0.66	0.40–1.04	0.07
BP + VD treatment	0.24	0.07–0.75	0.01

CI confidence interval, GC glucocorticoid, BMD bone mineral density, BP bisphosphonate, VD vitamin D agent
^aPrednisolone equivalents
^bSmaller value of T-score was taken either for the lumber spine or femoral neck measurement

ISSN: 1478-6362